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Diabetes, a disease with significant morbidity and premature 
mortality, is affecting increasing numbers of people worldwide. 
The World Health Organization (WHO) estimated that in 1998 
there were 135 million people with diabetes.1 The estimate rose 
to 171 million people in 2000 and has been projected to increase 
to 366 million in 2030.2  Much of the increase will occur in 
developing countries, arising from growth and ageing of the 
population as well as urbanisation associated with increasing 
trends towards unhealthy diets, obesity and sedentary 
lifestyles resulting in late-onset diabetes (type 2).3 The global 
trend of increasing obesity will exacerbate the situation and 
is very concerning as the morbidity and health care costs 
associated with diabetes are considerable. Diabetes is not only 
the most common cause of non-traumatic amputations and 
a leading cause of blindness, it also accounts for a significant 
proportion of end-stage renal disease requiring dialysis and 
transplantation. Good quality care and management of diabetes 
can reduce the impact of these complications. However, in 
developing countries, competing needs restrict the capacity of 
resource-limited health services to achieve these reductions. 
Globally, diabetes is also an increasingly important cause of 
mortality. When the excess mortality attributed to diabetes was 
taken into account, it was estimated to be the 5th leading cause 
of death in the year 2000 accounting for 5.2% of all deaths 
globally,4 with heart disease, stroke and renal failure largely 
accounting for the additional deaths. 
Unlike the situation with hypertension and high body mass, 
no national prevalence statistics for diabetes are available in 
South Africa. However, a number of epidemiological studies 
have been conducted in selected communities in the 1980s 
and 1990s.5-10 These revealed a clear rural-urban gradient with 
higher prevalence in urban settings, in addition to a gradient 
across different population groups. Studies reported the 
highest prevalence in the Indian population, followed by the 
coloured and then the black population. There is little data 
on the prevalence of diabetes among whites. Based on the 
available epidemiological data, approximately 1 - 1.5 million 
South Africans are considered to have diabetes. The South 
African National Burden of Disease Study11 reported that 
diabetes was the 10th leading cause of death among persons 
of all ages in 2000, accounting for an estimated 13 500 deaths 
(2.6% of the total). This estimate reflects deaths where diabetes 
would be selected as the underlying cause but excludes the 
excess deaths resulting from the increased risk of mortality 
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Objectives. To estimate the burden of disease attributable to 
diabetes by sex and age group in South Africa in 2000.
Design. The framework adopted for the most recent World 
Health Organization comparative risk assessment (CRA) 
methodology was followed. Small community studies used to 
derive the prevalence of diabetes by population group were 
weighted proportionately for a national estimate. Population-
attributable fractions were calculated and applied to revised 
burden of disease estimates. Monte Carlo simulation-modelling 
techniques were used for uncertainty analysis.
Setting. South Africa.
Subjects. Adults 30 years and older.
Outcome measures. Mortality and disability-adjusted life years 
(DALYs) for ischaemic heart disease (IHD), stroke, hypertensive 
disease and renal failure.
Results. Of South Africans aged ≥ 30 years, 5.5% had diabetes 
which increased with age. Overall, about 14% of IHD, 10% of 
stroke, 12% of hypertensive disease and 12% of renal disease 
burden in adult males and females (30+ years) were attributable 
to diabetes. Diabetes was estimated to have caused 22 412 (95% 
uncertainty interval 20 755 - 24 872) or 4.3% (95% uncertainty 
interval 4.0 - 4.8%) of all deaths in South Africa in 2000. Since 
most of these occurred in middle or old age, the loss of healthy 
life years comprises a smaller proportion of the total 258 028 
DALYs (95% uncertainty interval 236 856 - 290 849) in South 
Africa in 2000, accounting for 1.6% (95% uncertainty interval 
1.5 - 1.8%) of the total burden.  
Conclusions. Diabetes is an important direct and indirect cause 
of burden in South Africa. Primary prevention of the disease 
through multi-level interventions and improved management 
at primary health care level are needed.  
S Afr Med J 2007; 97: 700-706.
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from cardiovascular disease that is associated with diabetes or 
diabetes-related renal failure that is misclassified. Although not 
included in the global risk factor assessment,12 diabetes was 
identified by the South African National Department of Health 
as a risk factor of major concern. The aim of the present study 
is to quantify the burden of disease in terms of deaths and loss 
of healthy life years (DALYs) attributed to diabetes by sex and 
age group in South Africa for the year 2000. 
Methods 
Comparative risk assessment (CRA) methodology developed 
by the World Health Organization12,13 was used. In addition 
to the burden directly attributed to diabetes estimated in the 
South African National Burden of Disease study for 2000, 
the additional attributable burden is assessed by calculating 
the attributable fraction from estimates of the prevalence of 
diabetes in the population and the relative risk (RR) of selected 
health outcomes. Attributable burdens were calculated by 
applying the relevant population attributable fractions (PAFs) 
to the estimate of current disease burden. 
The prevalence of diabetes was estimated as a weighted 
average of the results from selected studies to represent 
subpopulations.5-9 The only data available to represent 
black Africans living in a rural area were collected in the 
former homeland of QwaQwa.8 The study by Levitt et al.5 
demonstrated a clear increase in the prevalence of diabetes 
associated with the length of stay in the urban area, and 
the 1998 South African Demographic and Health Survey 
(SADHS)14 showed that the prevalence of overweight and 
obesity among black Africans was twice as high in the urban 
setting compared with the rural setting. The prevalence 
data from QwaQwa were surprisingly high and similar to 
the urban township of Mangaung. This could be attributed 
to the close proximity of the former homeland to the urban 
setting. It was therefore decided to conservatively assume 
that the prevalence of diabetes in the rural area was half that 
estimated for the urban black population. Population weights 
for urban black Africans, rural black Africans and the other 
population groups were based on the Actuarial Society of 
South Africa population estimate for the year 2000 by age and 
sex. The population group classification is used in this article 
to demonstrate differences in the risk factor profile and the 
subsequent burden. Data are based on self-reported categories 
according to the population group categories used by Statistics 
South Africa. Mentioning such differences allows for a more 
accurate estimate of the overall burden and may assist in 
higher effectiveness of future interventions. The authors do 
not subscribe to this classification for any other purpose. The 
revised World Health Organization criteria15 were used to 
define the presence of diabetes, i.e. a venous plasma glucose 
concentration of ≥ 7 and/or ≥ 11.1 mmol/l taken 2 hours after a 
75 g oral glucose challenge.
The outcomes assessed were ischaemic heart disease (IHD), 
stroke, hypertensive disease and renal failure (nephritis/
nephrosis excluding hypertensive renal disease). According 
to International Classification of Diseases (ICD) rules,16 diabetes 
should be recorded as the underlying cause of death from 
end-stage renal failure caused by diabetes. As extensive 
misclassification has been observed as a result of incomplete 
certification in other settings,17,18 and the need for better 
certification has been identified in South Africa,19 it was 
assumed that a proportion of the deaths ascribed to nephritis/
nephrosis were likely to have resulted from diabetes. A review 
of the literature provided several estimates of the RRs of 
these outcomes.20-33 However, the Asia Pacific Cohort Studies 
Collaboration34 includes most of the prospective observational 
studies conducted in both Indian and Caucasian populations 
in the region. It provides reliable evidence on the effects of a 
variety of modifiable risk factors, including diabetes, on the 
risks of major cardiovascular diseases and other common 
causes of death in populations from this region. The age- and 
sex-specific hazards (Table I) re-categorised to match the 
burden of disease age groups were used in this study.  As there 
were no relative risks published for hypertensive disease, the 
RR for all cardiovascular disease was used.
Customised MS Excel spreadsheets were used to calculate 
the attributable burden using the PAF formula for each age 
interval: 
where P is the prevalence of exposure and RR is the relative 
risk of disease in the exposed versus unexposed group. PAFs 
were then applied to revised South African burden of disease 
estimates for 2000 with methods and assumptions described 
elsewhere11 to calculate attributable burden (number of deaths, 
years of life lost (YLLs) due to premature mortality, years of 
life lived with disability (YLDs) and DALYs). Because of data 
limitations, all diabetes burden in adults 30 years and older 
was assumed to be type 2 diabetes.  
Monte Carlo simulation-modelling techniques were used to 
present uncertainty ranges around point estimates that reflect 
all the main sources of uncertainty in the calculations. We 
used the @RISK software version 4.5 for Excel,35 which allows 
multiple recalculations of a spreadsheet, each time choosing 
a value from distributions defined for input variables. For the 
prevalence of diabetes in adults aged 30+ we assumed that the 
weighted national estimates could vary by 20%, and specified 
a triangular distribution with three points (minimum, most 
likely and maximum). For the RR input variables we specified 
a normal distribution around the logged point estimate and 
its standard error derived from the published values and their 
95% confidence intervals (CIs) (Table I).  For each of the output 
variables (namely attributable burden as a percentage of total 
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burden in South Africa 2000), 95% uncertainty intervals were 
calculated bounded by the 2.5th and 97.5th percentiles of the 
2000 iteration values generated.
Results 
The estimated prevalence of diabetes among South African 
adults 30 years and older was 5.5% in 2000 and varied by age 
and sex, as can be seen from Fig. 1. The prevalence increased 
with age for both males and females, and although it was 
similar for males and females in the younger age groups, there 
was a marked difference over the age of 60 years.
The prevalence of diabetes varied by population group, 
as shown in Table II.  The Indian population group had the 
highest prevalence of diabetes. The prevalence was consistently 
higher for women of all population groups except for Indians. 
The prevalence of diabetes was also highest in the older 
age groups (60 years and older). In Indians there was also a 
marked increase in the 45 - 49-year age groups for both men 
and women. 
Table III gives a summary of the attributable burden in 
terms of deaths and DALYs resulting from each of the related 
conditions. Compared with other conditions, the PAFs were 
highest for IHD for both males and females. In adults 30 
years and older, diabetes caused 13 166 deaths in 2000 directly 
and a further 9 246 could be attributed through IHD, stroke, 
hypertensive disease and renal failure. Thus 22 412 (95% 
uncertainty interval 20 755 - 24 872) or 4.3% (95% uncertainty 
interval 4.0 - 4.8%) of all deaths were attributed to diabetes 
in South Africa in 2000. Almost half of the attributable deaths 
occurred among adults of working age: 47.2% of those who 
died were under 65 years. Fig. 2 shows the age and sex 
distribution of the deaths and highlights that the peak burden 
for men was in the age range 45 - 59 years, while for women it 
was higher and occurred in the age range 60 - 69 years. There 
were more attributable deaths in females than in males, and 
overall diabetes accounted for 5.7% of all female and 3.0% of 
all male deaths in South Africa in 2000. 
A total of 258 028 DALYs (95% uncertainty interval  
236 856 - 290 849) were attributable to diabetes. Although 
IHD accounted for more deaths than stroke in females, the 
DALYs for stroke were higher than those for IHD because of 
the greater disability component (YLDs) for stroke. Since most 
diabetes-related deaths occur in the elderly, the loss of life 
years accounts for a lower proportion of the total DALYs than 
deaths, i.e. 1.6% (95% uncertainty interval 1.5 - 1.8%) of the 
total.  
Table I. Adjusted hazard ratios for cardiovascular and renal 
disease 
Sex/Age (years) Hazard ratio 95% CI 
All ischaemic heart disease events (I20-I25)
   Males  2.03  (1.60 - 2.59)
   Females 2.54  (1.84 - 3.49)
   < 60  4.38  (2.63 - 7.31)
   60 - 74  2.44  (1.84 - 3.22)
   75+  1.57  (1.14 - 2.16)
Cerebrovascular deaths (I60-I69)
   Males  2.04  (1.46 - 2.84)
   Females 2.00  (1.37 - 2.92)
   < 60  2.57  (1.00 - 6.59)
   60 - 74  2.69  (1.91 - 3.80)
   75+  1.30  (0.86 - 1.96)
Non-fatal cerebrovascular events (I60-I69) 
   Male + female 2.09  (1.65 - 2.64)
All cardiovascular disease (I00-I26, I28-I84, I86-I99, J81)
   < 60  3.47  (2.30 - 5.21)
   60 - 74  2.27  (1.87 - 2.75)
   75+  1.49  (1.20 - 1.84)
Renal disease excluding cancer (N00-N19)
   Male + female 2.93  (1.70 - 5.04)
Source: Asia Pacific Cohort Studies Collaboration;34 ICD-10 codes.16 
Fig. 1. Estimated prevalence of diabetes by age and sex, South Africa, 
2000.
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Fig. 2. Diabetes-attributable mortality by cause, age and sex, South Africa, 
2000.
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Discussion  
This study estimated that over 20 000 deaths, accounting for 
4.3% of all deaths in South Africa in 2000, could be attributed 
to diabetes when excess mortality was taken into account. This 
places diabetes as the 7th commonest cause of death in this 
country, which is lower than the 5th place accorded to diabetes 
in the global study for the same year. In that report, Roglic et 
al.4 found that diabetes had a global mortality of 2.9 million 
deaths and accounted for 5.2% of all deaths. Not surprisingly, 
the South African estimates from our study fall between the 
lowest mortality (2.4%) reported for the poorest African and 
Western Pacific countries, and the highest mortality (~9%) in 
the Arabian Peninsula, East Mediterranean region, Canada 
and the USA. Interestingly, the global mortality attributable 
to HIV/AIDS and diabetes are similar, unlike the situation 
in South Africa where the former accounted for 6 times more 
deaths than diabetes in 2000.  
Yet our estimates for mortality attributable to diabetes may 
well be conservatively low. Firstly, they are based on cross-
sectional prevalence data obtained 5 - 15 years previously as 
current diabetes prevalence data were not available. Given 
global trends, these prevalences are likely to underestimate 
the prevalences for 2000. Secondly, RRs for IHD, stroke and 
renal disease from the Asia Pacific region were used because 
of the absence of available data from Africa.34 However, the 
INTERHEART study33 indicates that the RR for IHD at least 
may be higher for the black African population. Similarly, it is 
quite conceivable that the RR for deaths due to renal disease 
may be higher in South Africa than the Asia Pacific region. 
Although South Africa has well-developed public and private 
health sectors, there is strict rationing of renal replacement 
to the ~80% of the population served by the public sector. In 
this sector, renal replacement treatment is generally limited to 
patients under 60 years old who have stable employment and 
social support. The age cut-off tends to exclude the majority 
Table II. Prevalence (%) of diabetes by population group, age and sex, South Africa, 2000 
Population group Age group Males Females Persons
Urban black African  30 - 44      2.2          1.5         1.8
 45 - 59      9.2        13.0        11.2
 60 - 69    10.8        16.7        14.1
 70 - 79    10.8        16.7        14.3
 80+    10.8        16.7        14.7
 30+      5.4          7.3         6.4
Non-urban black African 30 - 44      1.1          0.8         0.9
 45 - 59      4.6          6.5         5.6
 60 - 69      5.4          8.4         7.1
 70 - 79      5.4          8.4         7.2
 80+      5.4          8.4         7.4
 30+      2.7          3.7         3.2
Coloured 30 - 44      0.8          0.4         0.6
 45 - 59      8.4          8.7         8.6
 60 - 69    12.5        33.3        24.3
 70 - 79    26.9        19.4        22.3
 80+    26.9        19.4        21.9
 30+      5.1          7.3         6.2
White  30 - 44      0.5          0.8         0.7
 45 - 59      7.3          8.2         7.7
 60 - 69    10.0        13.9        12.1
 70 - 79    10.8        16.7        14.3
 80+    10.8        16.7        14.9
 30+      5.1          7.3         6.2
Asian/Indian 30 - 44      9.6          9.8         9.7
 45 - 59    25.2        18.4        21.7
 60 - 69    30.0        30.0        30.0
 70 - 79    30.0        30.0        30.0
 80+    30.0        30.0        30.0
 30+    18.0        16.4        17.1
South Africa 30 - 44      1.6          1.3         1.4
 45 - 59      7.7          9.7         8.7
 60 - 69      9.6        15.1        12.6
 70 - 79    10.7        14.7        13.1
 80+    11.2        15.0        13.8
 30+      4.7          6.2         5.5 
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of people with endstage diabetic renal 
disease. Indeed, Moosa and Kidd36 
reported that only 6.2% of patients 
accepted for renal replacement therapy 
at a public sector tertiary hospital were 
diabetic. In contrast, approximately 
half of patients receiving long-term 
dialysis in the private sector have 
diabetes (Dr Charles Swanepoel, 
University of Cape Town – personal 
communication, 2007), akin to the 
situation in the developed countries. 
The South African diabetes age-
standardised mortality rate of about 
50 per 100 000 population is the 25th 
highest in the world,37 considerably 
higher than would be expected for a 
country with a diabetes prevalence 
in the mid-third of countries globally. 
The high mortality relative to the 
prevalence may well be a reflection of 
the suboptimal health care delivery for 
diabetes in this country.38-40 Inadequate 
glycaemia control, inadequate levels 
of hypertension control (which co-
exists in 50 - 60% of people with type 
2 diabetes), infrequent examination for 
complications of diabetes despite their 
common occurrence and lack of access 
to lipid-lowering therapy have all been 
reported by these studies. 
It is quite possible to reduce the 
burden due to diabetes in South 
Africa. There are unequivocal data that 
public health interventions can have 
a considerable impact on outcome 
in people with diabetes.  In a recent 
review, Narayan et al.41 examined the 
cost-effectiveness of interventions 
for preventing and treating diabetes 
in developing regions of the world 
and stratified these according to their 
feasibility and implementation priority. 
Feasibility was evaluated according to 
the level of difficulty in reaching the 
target population, the technological 
requirements or expertise, and the 
cultural acceptability and capital 
needed. In this exercise, interventions 
such as glycaemia control in people 
with a haemoglobin (HbA1c) level of > 
9%, blood pressure control in people 
with blood pressure > 160/95 mmHg 
and foot care in people with ulcers 
were assessed as highly feasible and 
cost-saving, and were also graded as 
having the greatest implementation 
priority in all developing regions of the 
world. South Africa has a considerably 
better health structure and greater 
resource allocation to health than the 
other sub-Saharan African countries. 
Thus it is conceivable that further 
interventions could be undertaken. 
The next stratum of interventions 
all cost $160 per DALY or less and 
include preconception care for women 
of reproductive age (cost-saving), 
lifestyle interventions for preventing 
type 2 diabetes (cost $60) and influenza 
vaccines among the elderly with type 2 
diabetes (cost $160 per DALY). 
A recent analysis,42 based on the 
evidence that cardiovascular mortality 
risk increases continuously with 
blood glucose levels, commencing 
well below the diagnostic threshold 
for diabetes, found that higher-than-
optimal blood glucose concentrations 
globally contributed a further 1 490 000 
deaths from IHD and 709 000 deaths 
from stroke to the 959 000 deaths 
directly attributed to diabetes globally. 
These data indicate that a significant 
proportion of all deaths due to IHD 
(21%) and stroke (13%) can be accounted 
for by non-optimal blood glucose levels 
and highlight the need for an integrated 
approach to the management of these 
interrelated diseases. Development of 
the chronic care model at the primary 
care level – including adequately 
trained nurses and other support staff, 
equipment and supply of drugs should 
assist in this regard. This challenge will 
be exacerbated by the potential growing 
numbers of HIV-positive people 
receiving antiretroviral treatment, as 
a proportion of those using protease 
inhibitors may be expected to develop 
diabetes.43
There is also the issue of diabetes 
prevention. A number of randomised 
trials41 have reported that intensive 
lifestyle intervention delays or prevents 
type 2 diabetes. There is a considerable T
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challenge in extending these findings to the general population 
and it would require major partnerships between government, 
communities, non-governmental organisations (NGOs) 
and industries, supporting shifts in social policy, such as 
creating environments conducive to increasing possibilities 
for safe physical activity and eating healthily. The national 
Department of Health has already launched the healthy 
lifestyle programme, but its implementation and uptake are 
uncertain. In the same vein, the first national guidelines for 
the management of diabetes at the primary care level were 
published in 1997, but this did not appear to impact on the 
quality of care because of problems with implementation. 
Indeed, sufficient policies for the management and prevention 
of diabetes and other chronic diseases have been developed at 
a national level. These however remain to be implemented by 
the provinces and local authorities. Clearly a new framework 
is critical to drive the successful implementation of national 
policies and guidelines. This requires an integrated platform 
between different levels of government, NGOs and industry to 
co-ordinate the implementation of these policies. Importantly, 
measures to evaluate these must also be put in place. 
Conclusions and recommendations 
In conclusion, the burden due to diabetes is unacceptably 
high in South Africa.  Intensive efforts are required to improve 
health care delivery such that the proportions of people 
achieving targets for blood pressure and blood glucose control, 
as well as receiving appropriate screening for complications 
with subsequent intervention, can achieve levels that will 
impact on morbidity and mortality. Colagiuri et al.44 argue that 
changes in social policy will be the key to changing the social 
and physical environment required to achieve widespread 
reductions in the incidence and prevalence of diabetes.
The launch of the Diabetes Strategy for Africa in December 
200645 is timeous as it outlines a plan of action and calls on 
governments, NGOs and industry to implement an integrated 
and comprehensive approach to reduce the burden of diabetes 
in the region. It advocates the continuum of interventions from 
primary prevention right through to palliative care. South 
Africa is well ahead in the diabetes epidemic but also has 
many of the resources required to place it at the forefront of 
implementing the plan of action. 
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